Concepedia

Armando Acevedo

AA

2

Publications

66

Citations

2

H-Index

2019

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Armando Acevedo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, vaccine safety, and vaccine development.

Top concepts

Publications per year

2019–2024

2

Publications

2

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho et al. · The Lancet Infectious Diseases · 2019 · 35 citations

, , +6

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants

Shabir A. Madhi, Eric A. F. Simões, Armando Acevedo et al. · The Journal of Infectious Diseases · 2024 · 31 citations · Full text

Rows per page

1–2 of 2